$LH 3 SEC Filings

Filed On	Filing
11 Feb 2026	Form 3: Sampson John H, Director No securities owned
12 Jan 2026	Form 3: Meltzer Jonathan C, EVP, Operations Holds 2,518.3256 shares of Common Stock
12 Jan 2026	Form 3: Kyle Kathryn W, EVP, Chief Legal Officer Holds 3,052.4574 shares of Common Stock
12 Jan 2026	Form 3: Vaughn Bryan T, EVP, Diagnostics Holds 5,146.5702 shares of Common Stock
03 Dec 2025	Form 3: Bulto Carulla Victor, Director No securities owned
03 Dec 2024	Form 3: Wang Julia Aijun, Chief Financial Officer, EVP No securities owned
04 Nov 2024	Form 3: Oyegunwa Akinbolade, EVP, CIO & CTO Holds 2,666.253 shares of Common Stock
09 Jun 2023	Form 3: Laboratory Corp Of America Holdings, 10% owner · Fortrea Holdings Inc Holds 100 shares of Common Stock
07 Jun 2023	Form 3: Rothman Paul, Director Holds 13 shares of Common Stock
08 May 2023	Form 3: Bailey Megan D., EVP, Chief Strategy Officer Holds 122 shares of Common Stock
08 May 2023	Form 3: DiVincenzo Jonathan P., EVP, Pres, Central Labs & Intl Holds 3,290.1354 shares of Common Stock
06 Apr 2023	Form 3: Graham Anita Z, EVP, CHRO Holds 30 shares of Common Stock
11 Jan 2023	Form 3: Pike Thomas, Pres & CEO Clinical Business No securities owned
13 Oct 2022	Form 3: Kliphouse Kirsten Marie, Director No securities owned
26 Mar 2021	Form 3: Wengel Kathryn E, Director No securities owned
04 Mar 2020	Form 3: Summy Amy B., EVP, Chief Marketing Officer No securities owned
04 Dec 2019	Form 3: Davis Jeffrey A., Director No securities owned
07 Nov 2019	Form 3: Schroeder Mark S, EVP, President-Diagnostics Lab Holds 178.6401 shares of Common Stock
01 Nov 2019	Form 3: Kirchgraber Paul R, CEO, Covance Drug Development Holds 4,407 shares of Common Stock
22 Oct 2019	Form 3: Seltz Judith C, Chief Human Resources Officer No securities owned

Comments